Clinical Trial Update: Evaluation of Heart Failure Treatment Guided by N-terminal Pro B-type Natriuretic Peptide (NTproBNP) vs Clinical Symptoms and Signs Alone [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating whether guiding heart failure therapy by NT-proBNP levels yields different outcomes than guidance by symptoms and signs alone; results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Left Ventricular Dysfunction

Snippet

Sponsor: AstraZeneca | Conditions: Heart Failure, Ventricular Dysfunction, Left | Phase 4 | Status: COMPLETED | Results posted: 2012-06-18